Marshall Goldsmith

FEBRUARY 8, 2018

Co-founder of Rose Park Advisors—Disruptive Innovation Fund. A leading thinker on strategy and breakthrough innovation. Teaches leadership to executives and emerging leaders around the world. Former Chairman and Chief Executive Officer Global Debt Registry (MHR). Corporate Executives.

Executive Coaching 70

Executive Coaching CEO Magazine Banking 70

Tanveer Naseer

MARCH 10, 2015

The following is a guest piece by Innovation Excellence co-founder Rowan Gibson. What most companies understand now is that the only way to drive profitable growth and wealth creation over the longer term is to innovate. Most senior executives respond to this question by describing what the company is or what it does.

How To 100

How To Retail Core Competence Innovation 100

Marshall Goldsmith

FEBRUARY 24, 2014

Every company wants “integrity,” “respect for people,” “quality,” “customer satisfaction,” “innovation,” and “return for shareholders.” Despite the lofty words, many of Enron’s top executives either have been indicted or are in jail.

Ethics 137

Ethics Pharmaceuticals PR Execution 137

The Horizons Tracker

NOVEMBER 29, 2023

However, the research also highlights the significance of diverse educational, industrial, and organizational backgrounds among managers and board members in fostering innovation in research and development (R&D), thereby generating both economic and social value. ” . ”

Diversity 96

Diversity Innovation Biotechnology Short-term 96

Harvard Business Review

AUGUST 3, 2016

That can benefit consumers through lower prices, more innovation, and better products. This is especially true in pharmaceutical markets where new and affordable drugs can improve and even save the lives of many people. Research has shown that pharma mergers reduce innovation. What’s the reason for this?

Innovation 8

Innovation Pharmaceuticals Company Price 8

Strategy Driven

DECEMBER 13, 2018

A few years back, I coached a national pharmaceutical team with distinct geographies. After 23 years as a corporate executive, he developed a reputation for building successful teams. Drawing from his own extensive background and 10 years of research, Douglas innovated the concept of “Team Quotient” (TQ).

Team 58

Team Pharmaceuticals Project Learning-by-Doing 58

The Horizons Tracker

FEBRUARY 22, 2022

billion and is estimated to be worth $48 billion by 2026, with the Covid pandemic driving growth, especially in the healthcare and pharmaceutical industries, but also in sectors such as automotive and defense. It’s a market that is already worth $3.1 “ There are cases with upload speeds of over 1Gbps. ” Immersive worlds.

Stephenson 87

Stephenson Wireless Christensen Automotive 87

Strategy Driven

NOVEMBER 29, 2016

Always at the forefront of innovation, technologies pioneered by the military are often adopted by the commercial sector; companies looking for cyber knowledge or network engineering skills can find this expertise among veterans. Bill Sebra is Chief Operations Executive at Korn Ferry Futurestep. About the Author.

Agility 50

Agility Pharmaceuticals Self-aware Crisis Management 50

Harvard Business Review

SEPTEMBER 21, 2018

Corporate directors and executives alike recognize that today’s pace of change continues to accelerate and that firms need to innovate to stay ahead. But are boards doing enough to support innovation, as they should? We found that, overall, innovation does not rank as a top strategic challenge for the majority of boards.

Innovation 10

Innovation Short-term Telecommunications Long-term 10

Lead on Purpose

SEPTEMBER 8, 2009

Over 150 companies, including Durkee, Cremora, San Giorgio, Ronzoni, and McCormick, now use the entire line of Flapper products, and Weatherchem continues to lead the industry in offering the widest, most innovative array of closure products. Filed under: Integrity , Leadership , Purpose , Team Building , Trust Tagged: | Albert J.

Committee 140

Committee Automotive Ethics Productivity 140

Harvard Business Review

SEPTEMBER 23, 2014

I often hear this question when I visit companies and speak about how to make an innovative idea less terrifying to high level executives. There are plenty of pundits arguing that big companies need to innovate, and pointing out that it is difficult to do so. Have you actually seen this done?”. The skepticism is warranted.

Innovation 11

Innovation P&L Short-term Company 11

Harvard Business Review

FEBRUARY 16, 2017

The same is true for social innovators. However, unlike many business leaders, it is easy for social innovators to overlook making an intentional effort to drive demand because the need for their innovation is so great. But even the most needed innovation does not sell itself. Consider that 86 million U.S.

Innovation 9

Innovation Rogers NGO Participative 9

Harvard Business Review

MARCH 14, 2017

For industries that depend on innovation, sustaining it is a constant challenge. These two actions cost almost nothing compared to vast sums often spent — and arguably, often wasted — on efforts to foster innovation. However, these prescriptions for innovation at Roivant have also led to some unexpected challenges.

Innovation 9

Innovation Company Incentives Industry 9

Strategy Driven

JULY 13, 2011

Since the unit’s reported financial results were so good, the executives at the corporate headquarters didn’t ask many questions about the drivers of the unit’s profits – until it was too late. Pharmaceutical companies have long needed deep scientific-innovation leadership capabilities but relatively few general managers.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Harvard Business Review

APRIL 19, 2016

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. Innovation, customization, speed, and location are also among the opportunities it offers. How could digital printing improve your innovation, product development, and speed to market? Threat analysis.

Supply Chain 8

Supply Chain Execution Analysis Technology 8

Coaching Tip

MARCH 15, 2011

All it takes is the desire to be innovative and creative in tackling a problem. If you’re a business owner or executive and your business is currently suffering, walk around and talk to all your employees. Entrepreneurship. You needn’t work for yourself – or even be working at all – to be an entrepreneur. What’s wrong here?

Pharmaceuticals 84

Pharmaceuticals Creativity Long-term Power 84

Harvard Business Review

JANUARY 27, 2016

Much fanfare has been paid to the term “disruptive innovation” over the past few years. Disruptive innovations are: Cheaper (from a customer perspective). New technologies, combined with business model innovation, provide the structural cost advantage necessary to take large chunks of the market over time.

Disruptive Innovation 8

Disruptive Innovation Innovation Short-term Long-term 8

Harvard Business Review

MARCH 28, 2012

The Swiss pharmaceutical giant Roche is nothing if not determined in its quest to acquire Illumina, the San Diego-based leader in genetic-sequencing equipment. An acquirer looking for innovation would have been likelier to try to buy Gateway, a company that is almost an after-thought now. billion tender offer directly to shareholders.

Innovation 12

Innovation Company Biotechnology CFO 12

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Besides Dr Reddy's, several leading Indian firms are pioneering polycentric innovation: Tata Motors. Polycentric innovation won't work in organizations that promote groupthink. Cambridge, U.K.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

JUNE 13, 2016

Since 1999, three years after OxyContin was unveiled by Purdue Pharmaceuticals, the rate of drug overdoses in the U.S. Meanwhile, the amount of prescription opioids sold by pharmaceutical companies has quadrupled, despite no proliferation in the amount of reported pain. And what can we learn from it?

Incentives 8

Incentives Pharmaceuticals Crisis P&L 8

Harvard Business Review

OCTOBER 6, 2016

In a Deloitte study of 7,000 organizations this year, 89% of executives rated “ strengthening the leadership pipeline ” an urgent issue. The culture at GE, for example, centers on execution, simplicity, and innovation. Investments in traditional leadership development are often misguided and a waste of money.

Leadership Pipeline 13

Leadership Pipeline Leadership After Action Review Pharmaceuticals 13

Harvard Business Review

SEPTEMBER 12, 2012

Business executives may not know it, but they are wasting billions of their gross profits on ineffective, even harmful drugs in their health plans. Equating "innovative" with new molecules misses the point: to develop clinically superior new medicines. —How dare the new Germany agency undermine innovative research!

Business Model 15

Business Model Company Pharmaceuticals Price 15

Harvard Business Review

MAY 7, 2015

In the pharmaceutical industry, technology is transforming the sales process. A few decades ago, pharmaceutical companies promoted their products almost entirely through personal contact by salespeople with physicians. Consequently, pharmaceutical companies now look beyond the sales force to reach physicians.

Trends 8

Trends Technology Pharmaceuticals Team 8

Harvard Business Review

MAY 8, 2013

Then, automation and the Web put senior executives in touch with their own front lines — and handed many MLMs their pink slips. Nearly 68% of these large-scale change and innovative efforts failed. These MLMs were alienated and felt senior executives had used them as tactical tools.

Middle Management 9

Middle Management Management Automotive Pharmaceuticals 9

Harvard Business Review

DECEMBER 27, 2016

But we would argue that credibility may also be signaled to important external stakeholders — future employees, patients, the pharmaceutical industry, donors, and so on. Core to the curriculum is emotional intelligence (with 360-degree feedback and executive coaching), teambuilding, conflict resolution, and situational leadership.

Management 15

Management 360-Degree Feedback Mayo Training 15

Harvard Business Review

AUGUST 9, 2012

Selling pharmaceuticals in Latin America is not the same as selling them in the United States or Western Europe. Second, in most Latin American countries, pharmaceutical companies are not allowed to advertise directly to consumers. Right off the bat, I can identify four big differences.

Pharmaceuticals 13

Pharmaceuticals Strategy Advertising Price 13

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. Life science company executives need to be thinking about what business they want to be in. They’re also sharing risk. The positions are there for the taking. But not for long.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

AUGUST 14, 2018

First, interviews were conducted with 40 senior business executives from six leading Western digital firms (Google, Yahoo, eBay, Amazon, Groupon, and Uber) and their corresponding direct competitors in China (Baidu, Sohu, Taobao, JD.com, Meituan, and Didi). ineffective innovation strategies. failure to fully embed operations in China.

Competitive Advantage 11

Competitive Advantage Business Model Technology Marketing 11

Harvard Business Review

OCTOBER 18, 2012

That's the blunt response from one African-American executive to a dilemma that dogs many people of color in American workplaces: Even as multicultural fluency is increasingly prized in today's global business environment, the very people who represent that diversity feel shut out. My style is direct," says one senior executive. "In

Diversity 16

Diversity Pharmaceuticals Uncertainty Focus Group 16

Harvard Business Review

FEBRUARY 29, 2016

We then tested the model using quantitative data about the incidence of safety-related errors in the context of pharmaceutical drugs. New executives take the helm. We analyzed 146 pharmaceutical firms between 1997 and 2004 for a quantitative look at this pattern of learning and forgetting after safety-based errors.

Organization 8

Organization McCombs Pharmaceuticals Learning-by-Doing 8

Harvard Business Review

FEBRUARY 17, 2011

Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). In effect, the VCs at Nadathur Holdings serve as the executive team for a miniature healthcare innovation ecosystem.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 13, 2012

Managers and business analysts will often be called upon to conduct data-driven experiments, to interpret data, and to create innovative data-based products and services. Executives in many industries are putting plans into place to beef up their workforce's skills. To thrive in this world, many will require additional skills.

Skills 17

Skills Pharmaceuticals Sample Business Intelligence 17

Harvard Business Review

JUNE 27, 2012

Paul is an old friend who, until his recent retirement, worked as a senior scientist at a pharmaceutical company, where he managed a group of innovative researchers. Some good scientists left the company, and others lost their innovative spark. A few years later, Paul was talking to a top executive of the acquiring company.

COO 11

COO Short-term Pharmaceuticals Innovation 11

Harvard Business Review

OCTOBER 7, 2014

The lesson: Frontline people can not only help the top leader validate an innovative new strategy, they can also be a powerful means to convince customers and those in higher levels at your company to buy in. . One day he observed a pharmaceuticals sales rep stop the car and run into a Costco for a few minutes. That’s pivotal.

CEO 11

CEO Strategy Pharmaceuticals B2B 11

Harvard Business Review

JULY 16, 2013

Consider the pharmaceutical industry, the focus of a recent global survey my colleagues and I conducted. We asked nearly 200 life sciences executives about long-term trends that posed fundamental threats to their businesses and how management was dealing with them. Competition Disruptive innovation Strategic planning'

Industry 8

Industry Pharmaceuticals Disruptive Innovation Strategic Planning 8

Harvard Business Review

MARCH 2, 2012

HBS welcomes 6,360 foreign nationals (64% of the total) to its executive education courses each year, enriching the experiences for Americans as well. As a consequence, these foreign-born executives become more interested in doing business with American companies and many will eventually work in the U.S.

Competitive Advantage 13

Competitive Advantage Globalization Development Intellectual Capital 13